C07C235/48 - CPC Classification Index

ClassID:

92842 ⎘

C07C235/48 - CPC Classification

Classification description:

Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms

Recent Application in this class:

20250120944

2025-04-17

ANTIBACTERIAL COMPOSITION

20250109094

2025-04-03

Process for the preparation of 2,4,6-triiodophenol derivatives

20230406813

2023-12-21

P62-ZZ CHEMICAL INHIBITOR

20230131121

2023-04-27

BRANCHED DISCRETE PEG CONSTRUCTS

20210395202

2021-12-23

Orally available sEH/PDE4 dual inhibitors

20210332004

2021-10-28

Polyfunctional cannabinoids

20210171441

2021-06-10

Phenyl derivatives as cannabinoid receptor 2 agonists

20200317612

2020-10-08

Branched Discrete PEG Constructs

20200216490

2020-07-09

PPAR agonists and methods of use thereof

#10

20200190019

2020-06-18

PPAR agonists

#11

20200031761

2020-01-30

P62-ZZ chemical inhibitor

#12

20190023709

2019-01-24

SHIP1 MODULATORS AND METHODS RELATED THERETO

#13

20180305403

2018-10-25

PPAR agonists and methods of use thereof

#14

20180297938

2018-10-18

Compounds for targeting drug delivery and enhancing siRNA activity

#15

20180251472

2018-09-06

Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same

#16

20180230084

2018-08-16

Benzo annulenes as antiviral agents

#17

20180170857

2018-06-21

PPAR agonists

#18

20180065922

2018-03-08

Benzoic acid amide compound

#19

20170320828

2017-11-09

Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof

#20

20170313656

2017-11-02

Branched discrete PEG constructs

#21

20170001950

2017-01-05

Compounds for targeting drug delivery and enhancing siRNA activity

#22

20170000893

2017-01-05

Compounds for targeting drug delivery and enhancing siRNA activity

#23

20160368860

2016-12-22

Amide derivative

#24

20160340293

2016-11-24

Catalyst composition for polymerization of olefins

#25

20160310471

2016-10-27

GLP-1 receptor stabilizers and modulators

#26

20160107996

2016-04-21

Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof

#27

20160023991

2016-01-28

PPAR agonists

#28

20150361030

2015-12-17

PERFLUOROPOLYVINYL MODIFIED ARYL INTERMEDIATES AND MONOMERS

#29

20150259448

2015-09-17

Catalyst composition for polymerization of olefins

#30

20150175607

2015-06-25

p62-ZZ chemical inhibitor

#31

20150148347

2015-05-28

Indanyloxyphenylcyclopropanecarboxylic acids

#32

20150045387

2015-02-12

Bi-Aromatic And Tri-Aromatic Compounds As NADPH Oxidase 2 (Nox2) Inhibitors

#33

20140374657

2014-12-25

Compound, liquid crystal composition, polymer material and film

#34

20140336185

2014-11-13

GLP-1 receptor stabilizers and modulators

#35

20140234241

2014-08-21

Benzoic acid amide compound

#36

20140135518

2014-05-15

Perfluoropolyvinyl modified aryl intermediates and monomers

#37

20140038980

2014-02-06

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease

#38

20130338364

2013-12-19

Iodoarene derivative, method for manufacturing optically active spirolactone compound by using the same, and method for manufacturing optically active cycloadduct

#39

20130261133

2013-10-03

Therapeutic Compounds for Protozoal and Microbial Infections and Cancer

#40

20130253038

2013-09-26

Modified single-stranded polynucleotides

#41

20130245128

2013-09-19

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's

#42

20130059853

2013-03-07

Biaryl phosphodiesterase inhibitors

#43

20130052130

2013-02-28

Branched Discreet PEG Constructs

#44

20130017249

2013-01-17

Compounds for targeting drug delivery and enhancing siRNA activity

#45

20130012536

2013-01-10

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#46

20120322761

2012-12-20

Heterocyclic CETP inhibitors

#47

20120283287

2012-11-08

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

#48

20120225890

2012-09-06

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease

#49

20120190861

2012-07-26

Levodopa Prodrugs, and Compositions and Uses Thereof

#50

20120088926

2012-04-12

Process for the preparation of a iodinating agent

#51

20120088782

2012-04-12

LPA RECEPTOR ANTAGONIST

#52

20120035179

2012-02-09

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#53

20110312092

2011-12-22

Dual-terminal amide hydrogelling agent

#54

20110201817

2011-08-18

Levodopa prodrugs, and compositions and uses thereof

#55

20110172239

2011-07-14

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease

#56

20110130384

2011-06-02

AMIDE COMPOUND

#57

20100331567

2010-12-30

Process for the iodination of aromatic compounds

#58

20100267669

2010-10-21

Heterocyclic CETP inhibitors

#59

20100249157

2010-09-30

LPA receptor antagonist

#60

20100197953

2010-08-05

Levodopa prodrugs, and compositions and uses thereof

#61

20100179326

2010-07-15

Benzamide derivative

#62

20100144720

2010-06-10

INHIBITORS OF HUMAN TUMOR-EXPRESSED CCXCKR2

#63

20100137445

2010-06-03

PLANT DISEASE CONTROL AGENT, AND PLANT DISEASE CONTROL METHOD

#64

20100125090

2010-05-20

Modulators of ATP-Binding Cassette Transporters

#65

20100105647

2010-04-29

Amide compound and use thereof for controlling plant diseases

#66

20100081782

2010-04-01

Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same

#67

20100069453

2010-03-18

Certain Chemical Entities, Compositions, and Methods

#68

20100056640

2010-03-04

Amide compound and use thereof

#69

20100048701

2010-02-25

Amide compound and use thereof for controlling plant diseases

#70

20090312365

2009-12-17

Imidazopyridinyl benzamide mitotic kinesin inhibitors

#71

20090306127

2009-12-10

Imidazopyridinyl benzamide mitotic kinesin inhibitors

#72

20090286841

2009-11-19

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

#73

20090197965

2009-08-06

COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE

#74

20090177008

2009-07-09

NOVEL PROCESS FOR SYNTHESIS OF ITOPRIDE AND ITS NOVEL INTERMEDIATE N-(4-HYDROXYBENZYL)- 3,4-DIMETHOXYBENZAMIDE

#75

20090143374

2009-06-04

Use of compounds and compositions for the treatment of amyloid diseases

#76

20090137834

2009-05-28

LEVODOPA PRODRUGS, AND COMPOSITIONS AND USES THEREOF

#77

20090131531

2009-05-21

Amide compounds and their use

#78

20090111183

2009-04-30

Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#79

20090076152

2009-03-19

Novel Compounds Active as Muscarinic Receptor Antagonists

#80

20090069432

2009-03-12

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease

#81